1. Human papillomavirus testing in the prevention of cervical cancer;Schiffman;J Natl Cancer Inst,2011
2. Risk of high grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial;Carozzi;Lancet Oncol,2012
3. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study;Schiffman;Cancer Epidemiol Biomarkers Prev,2011
4. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia;Cuschieri;Cancer Epidemiol Biomarkers Prev,2008
5. Wentzensen N, Wacholder S. From differences in means between cases and controls to risk stratification: a business plan for biomarker development. Cancer Discovery (in press).